184 related articles for article (PubMed ID: 33166766)
1. Baicalein suppresses growth of non-small cell lung carcinoma by targeting MAP4K3.
Li J; Yan L; Luo J; Tong L; Gao Y; Feng W; Wang F; Cui W; Li S; Sun Z
Biomed Pharmacother; 2021 Jan; 133():110965. PubMed ID: 33166766
[TBL] [Abstract][Full Text] [Related]
2. MAP4K3 mediates amino acid-dependent regulation of autophagy via phosphorylation of TFEB.
Hsu CL; Lee EX; Gordon KL; Paz EA; Shen WC; Ohnishi K; Meisenhelder J; Hunter T; La Spada AR
Nat Commun; 2018 Mar; 9(1):942. PubMed ID: 29507340
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
Cathcart MC; Useckaite Z; Drakeford C; Semik V; Lysaght J; Gately K; O'Byrne KJ; Pidgeon GP
BMC Cancer; 2016 Sep; 16(1):707. PubMed ID: 27586635
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway.
Zhou Y; Hong T; Tong L; Liu W; Yang X; Luo J; Wang F; Li J; Yan L
Int J Mol Med; 2018 Dec; 42(6):3093-3104. PubMed ID: 30221690
[TBL] [Abstract][Full Text] [Related]
5. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
[TBL] [Abstract][Full Text] [Related]
6. The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.
Song KH; Kang JH; Woo JK; Nam JS; Min HY; Lee HY; Kim SY; Oh SH
BMC Cancer; 2014 Jan; 14():31. PubMed ID: 24438088
[TBL] [Abstract][Full Text] [Related]
7. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
Li F; Zhu T; Cao B; Wang J; Liang L
Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
[TBL] [Abstract][Full Text] [Related]
8. Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer.
Wang J; Hu T; Wang Q; Chen R; Xie Y; Chang H; Cheng J
Cancer Lett; 2021 Jul; 509():89-104. PubMed ID: 33848520
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
10. CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy.
Cai J; Li R; Xu X; Zhang L; Lian R; Fang L; Huang Y; Feng X; Liu X; Li X; Zhu X; Zhang H; Wu J; Zeng M; Song E; He Y; Yin Y; Li J; Li M
Nat Cell Biol; 2018 Apr; 20(4):465-478. PubMed ID: 29593330
[TBL] [Abstract][Full Text] [Related]
11. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
López-Plana A; Fernández-Nogueira P; Muñoz-Guardiola P; Solé-Sánchez S; Megías-Roda E; Pérez-Montoyo H; Jauregui P; Yeste-Velasco M; Gómez-Ferreria M; Erazo T; Ametller E; Recalde-Percaz L; Moragas-Garcia N; Noguera-Castells A; Mancino M; Morán T; Nadal E; Alfón J; Domènech C; Gascon P; Lizcano JM; Fuster G; Bragado P
Int J Cancer; 2020 Aug; 147(4):1163-1179. PubMed ID: 31943158
[TBL] [Abstract][Full Text] [Related]
12. miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1.
Deng H; Qianqian G; Ting J; Aimin Y
Biomed Pharmacother; 2018 Oct; 106():1072-1081. PubMed ID: 30119173
[TBL] [Abstract][Full Text] [Related]
13. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
14. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
[TBL] [Abstract][Full Text] [Related]
15. Cordycepin induces autophagy-mediated c-FLIPL degradation and leads to apoptosis in human non-small cell lung cancer cells.
Yu X; Ling J; Liu X; Guo S; Lin Y; Liu X; Su L
Oncotarget; 2017 Jan; 8(4):6691-6699. PubMed ID: 28035061
[TBL] [Abstract][Full Text] [Related]
16. Baicalein suppresses non small cell lung cancer cell proliferation, invasion and Notch signaling pathway.
Su G; Chen H; Sun X
Cancer Biomark; 2018; 22(1):13-18. PubMed ID: 29614624
[TBL] [Abstract][Full Text] [Related]
17. W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors.
Liang D; Wang HY; Fan S; Wang J; Shen Y; Gao CY; Wu ML; Lu SM; Zhang SQ; Han W
Invest New Drugs; 2020 Oct; 38(5):1218-1226. PubMed ID: 31823159
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy.
Xu CX; Zhao L; Yue P; Fang G; Tao H; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Cancer Biol Ther; 2011 Sep; 12(6):549-55. PubMed ID: 21738008
[TBL] [Abstract][Full Text] [Related]
19. Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway.
Xie YJ; Gao WN; Wu QB; Yao XJ; Jiang ZB; Wang YW; Wang WJ; Li W; Hussain S; Liu L; Leung EL; Fan XX
Pharmacol Res; 2020 Sep; 159():104934. PubMed ID: 32464330
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR.
Li J; Deng H; Hu M; Fang Y; Vaughn A; Cai X; Xu L; Wan W; Li Z; Chen S; Yang X; Wu S; Xiao J
Oncotarget; 2015 Mar; 6(9):6749-61. PubMed ID: 25730907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
